IGHG3 and neoplasm: Modifications to the existing hinge e.g. use of the extended hinge from human IgG3, may therefore move the fusion protein away from the critical FcγRs and C1q binding sites and thereby reinstate effector functions to hexameric Fc-fusions that are critical for tumour cell killing and clearance.